TRPV4 and chronic cystitis: Furthermore, Charrua et al. observed that the synergic effects of TRPV1 antagonist (RN1734) and TRPV4 antagonist (SB366791) could reverse the bladder hyperactivity of lipopolysaccharide (LPS)-induced cystitis at very low doses.